$3.95
-0.11-2.71%
At close: Jul 13, 5:00 PM EST
$3.90
-0.0498-1.26%
After Hours: 5:21 PM EST
AVITA Medical Inc Stock Guidance
RCELNASDAQ
AVITA Medical (RCEL) last issued guidance on May 14, 2026 for fiscal year 2026. The company guided revenue in the range of $80.00M - $85.00M for the period.
Compared to prior guidance, AVITA Medical maintained its revenue forecast from a prior range of $80.00M - $85.00M.
AVITA Medical has issued 38 guidance updates between August 11, 2022 and May 14, 2026. During this period, the company raised its outlook 7 times and lowered it 18 times, providing investors with insight into management's evolving expectations.
Latest Guidance Date
May 14, 2026
Guidance Period
Full Year 2026
Revenue Guidance Range
$80.00M - $85.00M
AVITA Medical Guidance History
Review all historical guidance issued by AVITA Medical, including EPS and revenue forecasts across quarterly and annual periods.
Loading calendar...
FAQ
What is the most recent guidance for AVITA Medical (RCEL)?
The most recent guidance for AVITA Medical (RCEL) was reported on May 14, 2026 for the fiscal year 2026. AVITA Medical forecasted revenue between $80.00M and $85.00M for the period.
What revenue range did AVITA Medical (RCEL) guide for?
AVITA Medical (RCEL) guided revenue in the range of $80.00M to $85.00M for the fiscal year 2026.
Did AVITA Medical (RCEL) raise or lower guidance?
AVITA Medical (RCEL) maintained its revenue guidance from a prior range of $80.00M - $85.00M to $80.00M - $85.00M for the fiscal year 2026.
When did AVITA Medical (RCEL) last issue guidance?
AVITA Medical (RCEL) last issued guidance on May 14, 2026 for the fiscal year 2026.
